Keegan Kevin G, Messer Nat T, Reed Shannon K, Wilson David A, Kramer Joanne
Department of Veterinary Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA.
Am J Vet Res. 2008 Feb;69(2):167-73. doi: 10.2460/ajvr.69.2.167.
To determine the effectiveness of administering multiple doses of phenylbutazone alone or a combination of phenylbutazone and flunixin meglumine to alleviate lameness in horses.
29 adult horses with naturally occurring forelimb and hind limb lameness.
Lameness evaluations were performed by use of kinematic evaluation while horses were trotting on a treadmill. Lameness evaluations were performed before and 12 hours after administration of 2 nonsteroidal anti-inflammatory drug (NSAID) treatment regimens. Phenylbutazone paste was administered at approximately 2.2 mg/kg, PO, every 12 hours for 5 days, or phenylbutazone paste was administered at approximately 2.2 mg/kg, PO, every 12 hours for 5 days in combination with flunixin meglumine administered at 1.1 mg/kg, IV, every 12 hours for 5 days.
Alleviation of lameness was greater after administration of the combination of NSAIDs than after oral administration of phenylbutazone alone. Improvement in horses after a combination of NSAIDs did not completely mask lameness. Five horses did not improve after either NSAID treatment regimen. All posttreatment plasma concentrations of NSAIDs were less than those currently allowed by the United States Equestrian Federation Inc for a single NSAID. One horse administered the combination NSAID regimen died of acute necrotizing colitis during the study.
Administration of a combination of NSAIDs at the dosages and intervals used in the study reported here alleviated the lameness condition more effectively than did oral administration of phenylbutazone alone. This may attract use of combinations of NSAIDs to increase performance despite potential toxic adverse effects.
确定单独多次给予苯基布他松或苯基布他松与氟尼辛葡甲胺联合使用对减轻马匹跛行的效果。
29匹自然发生前肢和后肢跛行的成年马。
当马在跑步机上小跑时,使用运动学评估进行跛行评估。在给予2种非甾体抗炎药(NSAID)治疗方案之前和之后12小时进行跛行评估。苯基布他松糊剂以约2.2mg/kg的剂量口服,每12小时给药1次,持续5天;或者苯基布他松糊剂以约2.2mg/kg的剂量口服,每12小时给药1次,持续5天,并联合氟尼辛葡甲胺以1.1mg/kg的剂量静脉注射,每12小时给药1次,持续5天。
NSAIDs联合使用后跛行的减轻程度大于单独口服苯基布他松。NSAIDs联合使用后马匹的改善并未完全掩盖跛行。5匹马在任何一种NSAID治疗方案后均未改善。所有NSAIDs治疗后的血浆浓度均低于美国马术联合会目前允许的单一NSAID的浓度。在研究期间,1匹接受NSAIDs联合治疗方案的马死于急性坏死性结肠炎。
按本研究报告的剂量和间隔给予NSAIDs联合用药比单独口服苯基布他松更有效地减轻了跛行状况。尽管存在潜在的毒性不良反应,但这可能会吸引人们使用NSAIDs联合用药来提高马匹的表现。